Roche has launched its SeqCap RNA Target Enrichment System for RNA-seq applications. The offering includes lncRNA design and custom enrichment options. The kit enables researchers to design customized targeted RNA-seq panels that focus on a subset of genes or transcripts.
Eurofins Genomics and Igenbio are now offering tailored sequencing and analysis services for microbial, fungal, and algal organisms. The service combines sequencing by Eurofins and bioinformatics by Igenbio.
Omicia is integrating Phevor, the Phenotype Driven Variant Ontological Re-ranking tool, into its Opal product, including Opal Clinical. Phevor is an algorithm co-developed by Omicia and researchers at the University of Utah to identify disease-relevant variants in genomic sequences.
Researchers at the University of California, Santa Cruz have launched Genome Browser in a Box, which enables researchers to install the UCSC Genome Browser on their own computers in about an hour.
Enzymatics has launched its Archer FusionPlex FGFR and NTRK panels. The FGFR panel detects known and novel fusions in the FGFR1, FGFR2, and FGFR3 genes. The FGFR genes, fibroblast growth factor receptor genes, are some of the most frequently amplified and mutated genes in cancer and are also promising targets for tyrosine kinase inhibitors, according to the company. The NTKR panel detects gene fusions to NTRK1, NTRK2, and NTRK3, which are found in cancers such as adenocarcinoma, high-grade glioma, pilocytic astrocytoma, and leukemia.